mHealth Spot

The Series D round was led by General Catalyst Partners with participation from DAG Ventures and existing investors, Mayfield, Benchmark and Tenaya.

The funds will be used to expedite an FDA approval for the adult diagnostic test, expand into in-clinic use, and enter European and Asian markets.

Together with Allergy & Asthma Network, the company will develop a series of services for people with asthma and allergies.

The company has developed an e-commerce platform that enables customers to buy a test kits online, collect their sample at home, and quickly get their results.

The retail pharmacy is also introducing a new pickup option as a branded experience called CVS Express, which will be accessible within its own mobile app.

The solution is easy to use, and can adapt to any medication routine; also, it works whether a person manages their own or a loved one's pill regimen.

Series A round was provided by JVP, Samsung, Bosch and the Tel Aviv University Momentum Fund and will be used to expand the company's staff.

The pilot program involves 550 of nearly 1,800 Target stores and is expected to be in place by May.

The program was sponsored entirely by Talkspace with the idea that mental health care should not be a privilege for the rich, but a right of every human being.

Under the deal, registered users of the mySugr app will get the ability to automatically upload blood glucose data from the Accu-Chek Connect meter.